Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Journal of Medicinal Chemistry
|
June 17, 2016
Discovery and Structure-Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1)
John L Gilmore, James E Sheppeck, Scott H Watterson, et al.
Journal of Medicinal Chemistry
|
March 1, 2016
Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series
Scott H Watterson, Junqing Guo, Steve H Spergel, et al.
Journal of Medicinal Chemistry
|
September 1, 2010
Discovery of 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases
Chunjian Liu, James Lin, Stephen T Wrobleski, et al.
Journal of Medicinal Chemistry
|
March 10, 2009
Novel tricyclic inhibitors of IkappaB kinase
James Kempson, Steven H Spergel, Junqing Guo, et al.
Medchemcomm
|
August 16, 2018
Identification of potent tricyclic prodrug S1P<sub>1</sub> receptor modulators
David Marcoux, Hai-Yun Xiao, T G Murali Dhar, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2016
Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials
T G Murali Dhar, Hai-Yun Xiao, Jenny Xie, et al.
Journal of Medicinal Chemistry
|
December 23, 2016
Asymmetric Hydroboration Approach to the Scalable Synthesis of ((1R,3S)-1-Amino-3-((R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986104) as a Potent S1P<sub>1</sub> Receptor Modulator
Michael G Yang, Zili Xiao, T G Murali Dhar, et al.
Journal of Medicinal Chemistry
|
November 30, 2004
The discovery of orally active triaminotriazine aniline amides as inhibitors of p38 MAP kinase
Katerina Leftheris, Gulzar Ahmed, Ran Chan, et al.
Journal of Medicinal Chemistry
|
April 3, 2026
Discovery of Non-prostanoid EP4 Agonists for the Treatment of Inflammatory Bowel Disease
Heidi L Perez, Sunita Dewnani, Steven A Spronk, et al.
Journal of Medicinal Chemistry
|
October 12, 2016
Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P<sub>1</sub>) Employing Ligand-Based Drug Design
Hai-Yun Xiao, Scott H Watterson, Charles M Langevine, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Journal of Medicinal Chemistry
|
June 17, 2016
Discovery and Structure-Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1)
John L Gilmore, James E Sheppeck, Scott H Watterson, et al.
Journal of Medicinal Chemistry
|
March 1, 2016
Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series
Scott H Watterson, Junqing Guo, Steve H Spergel, et al.
Journal of Medicinal Chemistry
|
September 1, 2010
Discovery of 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases
Chunjian Liu, James Lin, Stephen T Wrobleski, et al.
Journal of Medicinal Chemistry
|
March 10, 2009
Novel tricyclic inhibitors of IkappaB kinase
James Kempson, Steven H Spergel, Junqing Guo, et al.
Medchemcomm
|
August 16, 2018
Identification of potent tricyclic prodrug S1P<sub>1</sub> receptor modulators
David Marcoux, Hai-Yun Xiao, T G Murali Dhar, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2016
Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials
T G Murali Dhar, Hai-Yun Xiao, Jenny Xie, et al.
Journal of Medicinal Chemistry
|
December 23, 2016
Asymmetric Hydroboration Approach to the Scalable Synthesis of ((1R,3S)-1-Amino-3-((R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986104) as a Potent S1P<sub>1</sub> Receptor Modulator
Michael G Yang, Zili Xiao, T G Murali Dhar, et al.
Journal of Medicinal Chemistry
|
November 30, 2004
The discovery of orally active triaminotriazine aniline amides as inhibitors of p38 MAP kinase
Katerina Leftheris, Gulzar Ahmed, Ran Chan, et al.
Journal of Medicinal Chemistry
|
April 3, 2026
Discovery of Non-prostanoid EP4 Agonists for the Treatment of Inflammatory Bowel Disease
Heidi L Perez, Sunita Dewnani, Steven A Spronk, et al.
Journal of Medicinal Chemistry
|
October 12, 2016
Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P<sub>1</sub>) Employing Ligand-Based Drug Design
Hai-Yun Xiao, Scott H Watterson, Charles M Langevine, et al.
Page
of 6